QSC Tirzepatide is a synthetic peptide compound that functions as a dual agonist of both glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors. This unique mechanism makes it particularly valuable for metabolic research applications.
The compound has shown promising results in preliminary studies for regulating blood glucose levels and promoting weight management. Researchers have noted its potential effects on slowing gastric emptying, increasing satiety signals, and improving insulin sensitivity.
Our QSC Tirzepatide is supplied as a lyophilized powder in sterile vials, ensuring stability and ease of reconstitution for laboratory use. The product undergoes rigorous quality control testing to guarantee purity and consistency across batches.
For optimal preservation, store the peptide in a cool, dry environment protected from light exposure. Avoid repeated freeze-thaw cycles and prolonged exposure to air after reconstitution to maintain compound integrity.